Cori A. Lable

Partner Litigation
Kirkland & Ellis International LLP

Hong Kong +852 3761 3592

Cori A. Lable

Overview

Cori Lable is a partner in the Government & Internal Investigations Practice Group in the Hong Kong office of Kirkland & Ellis International LLP. She concentrates her practice on advising multinational clients throughout Asia on international risks related to cross-border investments and operations, including corruption, money laundering, economic sanctions, and financial fraud. Cori has extensive experience working with clients in the private equity, asset management, industrials, and pharmaceutical and medical device sectors facing regulatory and criminal enforcement actions related to potential violations of the Foreign Corrupt Practices Act and other U.S. securities, trade compliance, and export controls statutes. She has been named as a leading anti-corruption practitioner for India and China by Legal 500 Asia-Pacific and Chambers Asia, in which clients praised her “broad experience on compliance matters and internal investigations across Asia,” and described her as “really exceptional in terms of advice.” Cori’s practice spans the Asia-Pacific region, where she has led numerous investigations in jurisdictions including India, China, Japan, Korea, and Malaysia.

Cori also regularly advises clients on anti-corruption, anti-money laundering, and sanctions and trade compliance risk assessments and due diligence related to investments and acquisitions in Asia; global cybersecurity and data breach investigations and litigation; provides advice on the design and implementation of international risk compliance programs; and publishes and speaks frequently on these topics across Asia.

While at Kirkland, Cori's representative matters have included:

  • Advised Partners Group (SIX:PGHN) in the establishment of an investment platform in Singapore focusing on Indian real estate assets with the Xander Group acting as operator.

  • Represented a global animal health company in its long-term joint venture with its Chinese partner for the development, manufacture and sale of a vaccine in the PRC.

  • Lead Asia anti-corruption and international risks counsel to prominent global alternative asset management firm.

  • Lead anti-corruption and trade sanctions due diligence counsel for global merchant bank’s India, China, and Korea investments.

  • Lead counsel to global industrial manufacturer investigating anti-corruption and accounting fraud matters in India.

  • Lead counsel to global intermodal logistics company investigating potential anti-corruption matters in India, China, Korea, Indonesia, and Japan.

  • Lead counsel to leading medical device company investigating potential procurement and bid-rigging issues in Korea.

  • Independent legal counsel to Indian Insolvency and Bankruptcy Code resolution professional regarding U.S. economic sanctions and securities laws.

  • Lead anti-corruption, economic sanctions, and anti-money laundering training and compliance program implementation and monitoring for dozens of private equity portfolio companies across India, China, and South Asia.

Prior to joining Kirkland, Cori’s representative matters included:

  • Advised Blackstone on its joint venture with China Vanke, China’s largest residential developer, in the first transaction to receive clearance from the PRC Ministry of Commerce under the simplified merger filing procedure. Named “Real Estate & Construction Deal of the Year” for 2015 by China Law and Practice.

  • Anti-corruption and international risks counsel to multiple global private equity firms regarding investments across Asia-Pacific, including China, India, Vietnam, Korea, Indonesia, Myanmar, Japan, Australia, and New Zealand.

  • Lead counsel representing Chinese telecommunications executive in DOJ, Department of Commerce, and Department of Treasury export controls investigation.

  • Lead counsel to special litigation committee of leading Chinese ecommerce retailer regarding allegations of improper revenue recognition and other accounting-related misconduct.

  • Lead counsel to Fortune 50 client in SEC investigation involving allegations in Malaysia.

  • Represented multiple multinational life sciences clients in anti-corruption investigations in China, India, Korea, Japan, Malaysia, Singapore, and Taiwan.

  • Represented major medical device company regarding alleged FCPA violations across Asia-Pacific region.

  • Directed anti-corruption reviews of commercial sales, marketing, and distribution practices in UAE, Lebanon, Jordan, Yemen, Oman, Bahrain, Qatar, and Iran for leading global pharmaceutical company.

  • Defended prominent medical device company at trial against 13-count felony indictment, resulting in Department of Justice’s mid-trial dismissal of all felony charges in exchange for single misdemeanor resolution.

  • Represented multiple international investment advisers in investigations and litigation relating to foreign currency exchange transactions and practices.

Honorable Christopher F. DroneyUnited States District Court for the District of Connecticut

Partner, Ropes & Gray LLP

More

Thought Leadership

Publications

Co-author, "The U.S. Probe of Chinese Banks—What Counterparties Need to Know?" Bloomberg Law (September 6, 2019)

Co-author, "Shifting U.S. Enforcement Priorities—Should Chinese Companies be Worried?" Bloomberg Law (June 17, 2019)

Co-author, "A Shift in U.S. FCPA Policy—Should Chinese Companies be Worried?" Bloomberg Law (June 10, 2019)

Quoted, "From the March Issue: Adapting to Volatility," Asian Legal Business (March 27, 2019)

Co-author, "Anti-corruption due diligence in cross-border transactions," Thomson Reuters (March 19, 2019)

Quoted, “What's Next: Google & The Great Firewall, Plus Taking Net Neutrality to SCOTUS?” Law.com (August 8, 2018)

Co-author, “Heads or Tails? Are Europe’s GDPR and China’s Cybersecurity Law Two Sides of the Same Coin?” China Business Law Journal (May 25, 2018)

Quoted, “The GDPR and China's Cyber Law: Following One Doesn't Mean Following Both,” The American Lawyer (May 24, 2018)

Co-author, “Singapore Introduces Deferred Prosecution Agreements,” New York University Compliance and Enforcement Blog (April 4, 2018)

Co-author, “Challenges and Advice for Multinational Companies in Complying With Chinese Cybersecurity Law,” New York Law Journal (February 2018)

Co-author, “How Should Chinese Companies Face Increased U.S. Enforcement Risk From Their Global Business Operations?” China Business Law Journal (January 31, 2018)

Co-author, “U.S. Expands Efforts to Target Corrupt Foreign Officials,” Westlaw Journal on White-Collar Crime (August 2017)

Co-author, “Third parties – corruption risk and control,” Fraud Intelligence (June/July 2016)

Co-author, “Clearing India’s corruption hurdle,” PERE News (June 2016)

Co-author, “From Corruption To AML: The Future Of Chinese Enforcement,” Law360 (March 2016)

Co-author, “Bribery and Corruption Reporting Obligations: China,” Practical Law Global (July 2015) (updated August 2017)

Co-author, “Corruption and Bribery Concerns Affecting Japanese Pharmaceutical Companies Operating in the United States,” New York Pharma Forum (January 2015)

Seminars

Keynote Speaker, “Diligence and Compliance Pre- and Post-Transaction,” Exiger Lunch & Learn Seminar, Hong Kong (October 2018)

Presenter, “U.S. Economic Sanctions and Regulatory Developments Affecting Cross-Border Transactions,” Kirkland & Ellis Client Seminar, Tokyo (May 2018)

Moderator, “Focus: India,” Asialaw Asia-Pacific In-House Counsel Legal Summit, Hong Kong (May 2018)

Presenter, “Cybersecurity: Global Legal and Compliance Developments,” IDEX Legal Counsel Congress Roundtable, Mumbai (April 2017)

Panelist, “International White Collar Practice,” Women’s White Collar Defense Association Annual Meeting, Miami (March 2017)

Moderator, “What keeps us awake at night – the industry perspective,” Ethixbase - 2nd Asia Pacific Ethics & Compliance Summit, Singapore (November 2016)

Presenter, “Focus on India,” AdvaMed/APACMed Legal & Compliance Meeting, Singapore (November 2016)

Panelist, “Cybersecurity for Alternative Investments: Managing Operational and Regulatory Risks,” Eze Castle Integration Regulatory Seminar, Hong Kong (November 2016)

Panelist, “Trends in Compliance and Investigations,” Thomson Reuters APAC Legal Workshop, Hong Kong (May 2016)

Panelist, “Stake in India: Emerging Issues for Sophisticated Investors,” IDEX Legal Counsel Congress Roundtable, Mumbai, India (April 2016)

Panelist, “How to Control Risks When Working with Consultants and Facilitators,” ACI's 5th India Summit on Anti-Corruption, New Delhi, India (February 2016)

Panelist, “Cyber Crime and Virtual Currencies,” ABA Criminal Justice Section White Collar Crime Institute, Shanghai (November 2015)

Panelist, “Asia E-Discovery Best Practices,” Epiq Systems Strategic Advisory Meeting, Hong Kong (June 2015)

Panelist, “Legal and Practical Considerations in Conducting a Corruption or Fraud Investigation: The First 48 Hours,” Global Legal Confex, Delhi (April 2015)

Panelist, “Anti-Corruption Issues When Selling into China,” ABA Section of International Law Teleconference (June 2014)

Panelist, “Anti-Corruption Compliance in the Pharmaceutical and Medical Devices Industry,” Knowledge Congress Webinar (May 2014)

Presenter, Ropes & Gray/McKinsey & Company Shanghai Medical Device Roundtable (April 2014)

Recognition

“Dispute Resolution Star”, White Collar Crime, Benchmark Litigation Asia-Pacific (2019) 

Chambers Global: Corporate Investigations/Anti-Corruption (International Firms) — China (2018)

Chambers Asia: Leading Lawyer in Anti-Corruption/Investigations (2017, 2018)

Legal 500 Asia-Pacific: Leading Individual in Anti-Corruption and Compliance (2017, 2018)

Finalist, “Rising Star of the Year,” Asia-Pacific Dispute Resolution Awards (2015)

“Rising Star,” White-Collar Criminal Defense, Massachusetts Super Lawyers (2012–2015)

“Rising Star,” White-Collar Criminal Defense, Top Women Lawyers in Massachusetts (2013–2016)

Memberships & Affiliations

Mentor, Women in Law Hong Kong Mentoring Programme (2016–present)

Board of Directors, Playworks Massachusetts (2012–2014)

Member, Dana-Farber Cancer Institute Leadership Council

Credentials

Admissions & Qualifications

  • Hong KongRegistered Foreign Lawyer
  • 2004Massachusetts

Courts

  • United States District Court for the District of Massachusetts
  • United States Court of Appeals for the First Circuit
  • United States Court of Appeals for the Ninth Circuit

Education

  • Yale Law SchoolJ.D.2004
  • Cambridge UniversityM.Phil., Historical Studies2001
  • Yale UniversityB.A., Historymagna cum laude1998